Management of Cirrhotic Ascites / 胃肠病学

ABSTRACT

Ascites formation represents a hallmark of decompensation of liver cirrhosis and predicts a poor prognosis. Patients with cirrhotic ascites are at high risk of some complications,such as hyponatremia,hepatorenal syndrome and spontaneous bacterial peritonitis(SBP). Currently,there are consensuses on treatment with sodium intake restriction, diuresis,paracentesis,albumin supplement,anti-infection and etc. In recent years,some advancements have been achieved,such as aquaretics,vasoactive drugs,prevention of SBP with rifaximin,alfapump?,stem cell transplantation and etc.,and yet there are still many issues deserved to be researched. This article focused on the management of cirrhotic ascites and related controversies with reference to current international and local guidelines and latest evidences.